切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2018, Vol. 14 ›› Issue (04) : 453 -458. doi: 10.3877/cma.j.issn.1673-5250.2018.04.013

所属专题: 文献

论著

GCKR基因rs780094(C>T)多态性与妊娠期糖尿病发病风险的相关性分析
李亚妮1, 肖景华1,(), 吴益青1, 王艳霞1   
  1. 1. 710061 西安,西北妇女儿童医院妇产科
  • 收稿日期:2017-11-21 修回日期:2018-06-17 出版日期:2018-08-01
  • 通信作者: 肖景华

Correlation analysis between GCKR gene rs780094 (C>T) polymorphism and onset risk of gestational diabetes mellitus

Yani Li1, Jinghua Xiao1,(), Yiqing Wu1, Yanxia Wang1   

  1. 1. Department of Obstetrics and Gynecology, Northwest Women and Children′s Hospital, Xi′an 710061, Shaanxi Province, China
  • Received:2017-11-21 Revised:2018-06-17 Published:2018-08-01
  • Corresponding author: Jinghua Xiao
  • About author:
    Corresponding author: Xiao Jinghua, Email:
  • Supported by:
    Shaanxi Society Development Sci-Tech Research Project(2015SF135)
引用本文:

李亚妮, 肖景华, 吴益青, 王艳霞. GCKR基因rs780094(C>T)多态性与妊娠期糖尿病发病风险的相关性分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2018, 14(04): 453-458.

Yani Li, Jinghua Xiao, Yiqing Wu, Yanxia Wang. Correlation analysis between GCKR gene rs780094 (C>T) polymorphism and onset risk of gestational diabetes mellitus[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2018, 14(04): 453-458.

目的

探讨葡萄糖激酶调节蛋白(GCKR)基因rs780094(C>T)多态性与妊娠期糖尿病(GDM)发病风险的相关性。

方法

选择2013年2月至2016年7月,于西北妇女儿童医院妇产科就诊的252例孕妇为研究对象。其中127例为GDM孕妇,纳入GDM组;125例为健康孕妇,纳入对照组。收集2组孕妇的相关临床资料及实验室检测结果。GCKR基因rs780094(C>T)多态性基因型频率,采用实时荧光定量PCR法进行检测。采用成组t检验,对2组孕妇人体质量指数(BMI),总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、尿素浓度,以及总蛋白、白蛋白水平进行比较。采用Mann-Whitney U检验,对2组孕妇空腹血糖、75 g口服葡萄糖耐量试验(OGTT) 2 h血糖、三酰甘油、肌酐、尿酸浓度进行比较。采用χ2检验,对2组孕妇的妊娠期高血压疾病发生率、有糖尿病家族史所占比例,以及GCKR基因rs780094(C>T)多态性基因型、等位基因频率进行比较。本研究遵循的程序符合2013年修订的《世界医学协会赫尔辛基宣言》的要求,并与所有孕妇签署临床研究知情同意书。2组孕妇年龄等一般临床资料比较,差异均无统计学意义(P>0.05)。

结果

①与对照组孕妇相比较,GDM组孕妇BMI、妊娠期高血压疾病发生率、有糖尿病家族史所占比例及空腹血糖、75 g OGTT 2 h血糖、三酰甘油、尿酸浓度均显著升高,而总蛋白、白蛋白水平及肌酐、尿素浓度均显著降低,并且差异均有统计学意义(t=-8.087,χ2=7.280、135.428,Z=-2.752、-3.764、-4.657、-2.631,t=5.957、11.810,Z=2.389,t=6.528;P<0.05)。②GDM组和对照组孕妇GCKR基因rs780094(C>T)多态性基因型频率分布,均符合Hardy-Weinberg平衡定律(χ2=0.758、P=0.685, χ2=1.440、P=0.487)。在共显性模型下,GDM组孕妇GCKR基因rs780094(C>T)多态性CC、CT、TT基因型频率分别为50.4%(64/127)、37.8%(48/127)、11.8%(15/127),对照组分别为34.4%(43/125)、54.4%(68/125)、11.2%(14/125),2组比较,差异有统计学意义(χ2=7.589、P=0.022);在显性模型下,GDM组孕妇CC、CT+TT基因型频率分别为50.4%(64/127)、49.6%(63/127),对照组分别为65.6%(82/125)、11.2%(14/125),2组比较,差异亦有统计学意义(χ2=6.956、P=0.010)。对照组T等位基因频率为38.4%(96/250)。

结论

携带GCKR基因rs780094(C>T)多态性C等位基因的孕妇发生GDM的风险升高。因本研究纳入样本量相对较小,GCKR基因rs780094(C>T)多态性与GDM发病风险的相关性,尚需更多大样本、前瞻性随机对照研究结果证实。

Objective

To explore the correlation between GCKR gene rs780094 (C>T) polymorphism and the onset risk of gestational diabetes mellitus (GDM).

Methods

A total of 252 cases of pregnant women who were treated in Northwest Women and Children′s Hospital were selected as research subjects. They were divided into GDM group which included 127 cases of GDM pregnant women, and control group which included 125 cases of healthy pregnant women. The clinical and laboratory data of each group were collected. The genotypes of GCKR gene rs780094 (C>T) polymorphism were detected by PCR with fluorescent probes. Independent-samples t test was used to compare the body mass index (BMI), and concentrations of 1, 5-anhydro-D-glucitol (AG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and urea, and levels of total protein and albumin between two groups. Mann-Whitney U test was used to compare the concentrations of fasting blood glucose, 75 g oral glucose tolerance test (OGTT) 2 h blood glucose, trigalloyl glycerol, creatinine and uric acid between two groups. Chi-square test was used to compared the incidence of hypertensive disorder complicating pregnancy, the proportion of family history of diabetes, and genotype and allele frequencies of GCKR gene rs780094 (C>T) polymorphism between two groups. The study met the requirements of World Medical Association Declaration of Helsinki revised in 2013 and informed consents for clinical research were signed by all the pregnant women. There were no statistical differences between two groups in the aspects of age and other general clinical data (P>0.05).

Results

①Compared with pregnant women in control group, the BMI, incidence of hypertensive disorder complicating pregnancy, the proportion of family history of diabetes, and concentrations of fasting blood glucose, 75 g OGTT 2 h blood glucose, trigalloyl glycerol and uric acid were significantly increased in the GDM group, while levels of total protein and albumin, and concentrations of creatinine and urea were significantly decreased, and all the differences were statistically significant (t=-8.087, χ2=7.280, 135.428; Z=-2.752, -3.764, -4.657, -2.631; t=5.957, 11.810; Z=2.389, t=6.528; all P<0.05). ②The genotypes distributions of GCKR gene rs780094 (C>T) polymorphism of GDM group and control group both were in line with the Hardy-Weinberg equilibrium law (χ2=0.758, P=0.685; χ2=1.440, P=0.487). In codominant model of GCKR gene rs780094 (C>T) polymorphism, genotype frequencies of CC, CT and TT were 50.4% (64/127), 37.8% (48/127), and 11.8% (15/127), respectively in GDM group, and 34.4% (43/125), 54.4% (68/125), and 11.2% (14/125), respectively in control group, and there was statistically significant difference between two group in genotype frequencies of CC, CT and TT (χ2=7.589, P=0.022). In dominant model of GCKR gene rs780094 (C>T) polymorphism, genotype frequencies of CC and CT/TT were 50.4% (64/127) and 49.6% (63/127), respectively in GDM group, and 65.6% (82/125), 11.2% (14/125), respectively in control group, and there was statistically significant difference between two group in genotype frequencies of CC and CT/TT (χ2=6.956, P=0.010). The minor T allele frequency in the control group was 38.4% (96/250).

Conclusions

Pregnant women carriers of C allele GCKR gene rs780094 (C>T) polymorphism are more likely to develop into GDM. Because of the relatively small sample size in this study, the association between the GCKR gene rs780094 (C>T) polymorphism and the risk of GDM needs more large-sample prospective randomized controlled trials to confirm.

表1 2组孕妇相关临床资料及实验室检测结果比较
表2 2组孕妇GCKR基因rs780094(C>T)多态性基因型和等位基因频率比较[例数(%)]
[1]
American Diabetes Association. Standards of medical care in diabetes-2016 abridged for primary care providers[J]. Clin Diabetes, 2016, 34(1): 3-21.
[2]
Lowe WL Jr, Scholtens DM, Sandler V, et al. Genetics of gestational diabetes mellitus and maternal metabolism[J]. Curr Diab Rep, 2016, 16(2): 15-19.
[3]
Stride A, Shields B, Gill-Carey O, et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia[J]. Diabetologia, 2013, 57(1): 54-56.
[4]
Petta S, Miele L, Bugianesi E, et al. Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease[J]. PLoS One, 2014, 9(2): e87523.
[5]
董全勇,辛永宁,宣世英. 葡萄糖激酶调节蛋白基因多态性与非酒精性脂肪性肝病相关性的研究进展[J/CD]. 中国肝脏病杂志(电子版), 2015, 7(4): 22-25.
[6]
Lin YC, Chang PF, Chang MH, et al. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals[J]. Am J Clin Nutr, 2014, 99(4): 869-874.
[7]
Petit JM, Masson D, Guiu B, et al. GCKR polymorphism influences liver fat content in patients with type 2 diabetes[J]. Acta Diabetol, 2016, 53(2): 237-242.
[8]
López Rodríguez M, Kaminska D, Lappalainen K, et al. Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells[J]. Genome Med, 2017, 9(1): 63-70.
[9]
American Diabetes Association. 2. Classification and diagnosis of diabetes[J]. Diab Care, 2016, 39(Suppl 1): S13-S22.
[10]
Leon M, Moussa H, Longo M, et al. 842: Rate of GDM and pregnancy outcomes in chronic hypertensive pregnancies with and without gestational diabetes mellitus[J]. Am J Obstet Gynecol, 2015, 212(1): S403-S404.
[11]
Mook-Kanamori DO, Selim MM, Takiddin AH, et al. 1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control[J]. J Clin Endocrinol Metab, 2014, 99(3): E479-E483.
[12]
Boritza KC, dos Santos-Weiss IC, da Silva Couto Alves A, et al. 1,5 Anhydroglucitol serum concentration as a biomarker for screening gestational diabetes in early pregnancy[J]. Clin Chem Laborat Med, 2014, 52(8): e179-e181.
[13]
孔方方,赵玲娟,马振军,等. 2 891例妊娠合并糖代谢异常住院分娩患者的围生期结局变化情况分析[J/CD]. 发育医学电子杂志,2013, 1(2): 78-82.
[14]
余凡,廖海明,殷文静,等. 妊娠期糖尿病患者血糖波动与新生儿出生体重、母体及新生儿不良妊娠结局的相关性研究[J/CD]. 中华妇幼临床医学杂志(电子版), 2016, 12(3): 305-311.
[15]
倪明燕. 妊娠期糖尿病早期筛查与治疗对妊娠结局的影响[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(2): 188-191.
[16]
Hishida A, Morita E, Naito M, et al. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study[J]. Endocr J, 2012, 59(7): 589-599.
[17]
Stuebe AM, Wise A, Nguyen T, et al. Maternal genotype and gestational diabetes[J]. Am J Perinatol, 2014, 31(1): 69-76.
[18]
Huopio H, Cederberg H, Vangipurapu J, et al. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes[J]. Eur J Endocrinol, 2013, 169(3): 291-297.
[19]
Anghebem-Oliveira MI, Webber S, Alberton D, et al. The GCKR gene polymorphism rs780094 is a risk factor for gestational diabetes in a Brazilian population[J]. J Clin Laborat Anal, 2017, 31(2): e22035.
[20]
席金瓯. 血清1,5-脱水葡萄糖醇浓度测定在妊娠期糖尿病筛查中的应用[J]. 中国妇幼保健,2011, 26(32): 5075-5076.
[21]
Ling Y, Li X, Gu Q, et al. Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study[J]. BMC Med Genet, 2011, 12(1): 66.
[22]
Qi Q, Wu Y, Li H, et al. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population[J]. Diabetologia, 2009, 52(5): 834-843.
[23]
Sparsø T, Andersen G, Nielsen T, et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes[J]. Diabetologia, 2008, 51(1): 70-75.
[1] 申成凯, 孟飞, 刘坤, 朱卫洁, 赵海军. 白介素-1β基因型与原发性冻结肩易感性的关联研究[J/OL]. 中华关节外科杂志(电子版), 2024, 18(01): 17-23.
[2] 钱警语, 郑明明. 《2024意大利妇产科学会非侵入性和侵入性产前诊断指南》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 486-492.
[3] 黄蓉, 梁自毓, 祁文瑾. NLRP3炎症小体在胎膜早破孕妇血清中的表达及其意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 540-548.
[4] 何霞, 黄蓉, 祁文瑾. 胎膜早破孕妇胎盘与胎膜菌群丰度的高通量测序研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 549-555.
[5] 谢江燕, 王亚菲, 贺芳. 妊娠合并血栓性血小板减少性紫癜2例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 556-563.
[6] 徐婷婷, 詹泳池, 王晓东, 刘兴会. 电子胎心监测结果出现正弦波形的胎母输血综合征围生期结局分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 382-389.
[7] 韩肖燕, 杨桦. 中孕期孕妇血清胎盘生长因子水平低与胎儿不良预后的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 398-402.
[8] 杜佳丽, 鲍睿, 乔春红, 韩伟. 中孕期宫颈功能不全孕妇经阴道紧急宫颈环扎术后不良妊娠结局预测模型构建[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 403-409.
[9] 谭娟, 谭建新, 邵彬彬, 王艳, 许争峰. 胎儿单基因遗传病无创产前检测的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 245-250.
[10] 林雪, 陈锰, 杨梅琳, 刘兴会, 周红雨. 妊娠合并重症肌无力患者的围产结局和重症肌无力病情恶化的影响因素分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 125-132.
[11] 陈义思, 梁敏, 李红雨, 夏雪, 刘燕茜, 李晨曲, 王丹. 妊娠合并慢性肾病围产期多学科团队管理价值研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 133-139.
[12] 贾赛君, 张英, 万佳义. 妊娠合并亚临床甲状腺功能减退孕妇的妊娠结局[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 140-147.
[13] 李莉, 马梅, 黄欣欣, 杨丹林, 潘勉. 妊娠期糖尿病早孕期相关影响因素及基于早孕期孕妇糖脂相关生化指标与人口学资料的4种机器学习算法构建妊娠期糖尿病预测模型的临床价值[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(01): 105-113.
[14] 刘轩瑶, 赵晓曦. 孕妇常见产前筛查指标单独及联合检测对胎儿染色体异常的预测价值[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 657-664.
[15] 王叶青, 李利彤, 李伟绪, 曹猛. 牙周炎和糖尿病视网膜病变的因果关系:一项双向两样本孟德尔随机化分析[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 160-168.
阅读次数
全文


摘要